Newsroom | 11965 results
Sorted by: Latest
-
Vy Spine Announces FDA Clearance for VyBrate VBR System
BOUNTIFUL, Utah--(BUSINESS WIRE)--Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VyBrate VBR System which is designed for use in both the cervical and thoracolumbar spine for vertebral body replacement surgery. The VyBrate VBR is an innovative device combining the osseointegration properties of the OXPEKK material and the novel OsteoVy lattice structure...
-
LifeCenter Northwest Marks Record Year for Organ Donation in 2025
SEATTLE & SPOKANE, Wash.--(BUSINESS WIRE)--LifeCenter Northwest, the nonprofit organization that facilitates organ donation in Washington, Alaska and Montana announced today that collaboration with donor families and hospital partners across the region resulted in a record number of lives saved through organ donation in 2025, the most in the organization’s 28-year history. In 2025, LifeCenter Northwest: Supported 446 organ donor heroes in giving the gift of life. Coordinated 1,318 organ transpl...
-
FDA Files Rejoni’s Juveena® Hydrogel System PMA for the Prevention of Intrauterine Adhesions
BEDFORD, Mass.--(BUSINESS WIRE)--Rejoni, Inc., a clinical-stage company focused on uterine health, today announced that the U.S. Food and Drug Administration (FDA) has completed its filing review and formally filed the Premarket Approval (PMA) application for the Juveena Hydrogel System. In its filing notification, FDA stated that the submission contains the information needed to proceed with substantive review. The Juveena Hydrogel System is designed as a temporary spacer to help prevent the f...
-
Spineology Launches OptiMesh® HA Nano
ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., the pioneer in conforming patient-specific expandable implant technology, today announced the launch of OptiMesh HA Nano, the company’s latest advancement in personalized spinal care. The launch represents a significant step forward in expandable interbody fusion innovation, combining Spineology’s proprietary OptiMesh® expandable interbody implant platform with Promimic AB’s patented HA Nano Surface technology. OptiMesh HA Nano technology integ...
-
Ranpak and Medline Partner to Advance Automation and Sustainable Packaging Across High-Volume Distribution Operations
CONCORD TOWNSHIP, Ohio--(BUSINESS WIRE)--Ranpak announced a partnership with Medline Industries, the largest provider of medical-surgical products and supply chain solutions....
-
ZAP Surgical Announces Precision Radiomodulation Research Collaboration for Treatment-Resistant Depression
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for treatment-resistant depression (TRD) using the ZAP-X® Gyroscopic Radiosurgery® platform*. The study titled the Precision Radiomodulation Therapy Project for Depression is jointly led by Beijing Anding Hospital of Capital Medical University, Chinese PLA General Hospital...
-
Americhem to Spotlight New Materials Addressing PFAS, Traceability, and Performance Demands in Medical Devices at Pharmapack and MD&M West 2026
CUYAHOGA FALLS, Ohio--(BUSINESS WIRE)--As medical device manufacturers face mounting pressures to reduce environmental risk, improve traceability, and accelerate product development, Americhem is preparing to highlight a suite of new technologies that reflect these industry shifts at Pharmapack (Paris) and MD&M West (Anaheim) in early 2026. The company, known for its healthcare-focused polymer compounds and masterbatches, will showcase five key technologies, each designed to respond to the...
-
Vizient and AdventHealth Expand Agreement for Advanced Data and Digital Services
IRVING, Texas--(BUSINESS WIRE)--The expanded collaboration enhances AdventHealth’s access to Vizient’s robust data and digital offerings....
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced preliminary financial results for the fourth quarter and full year 2025 and provided 2026 financial guidance. Preliminary, unaudited revenue for fourth quarter 2025 is expected to be $140.5 million, reflecting growth of approximately 13% over the fourth quar...
-
EndoQuest to Bring AI-Powered Vision and Precision to Endoluminal Robotic Surgery with NVIDIA IGX Thor
HOUSTON--(BUSINESS WIRE)--EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced new initiatives as part of their collaboration with NVIDIA to integrate NVIDIA IGX Thor, an NVIDIA Blackwell-powered, enterprise-ready platform, into EndoQuest’s next-generation robotic system. The collaboration – focusing on integrating EndoQuest’s visualization system, robotic control, and secure cloud services using NVIDIA’s Physical AI software stack – aims to...